Question 1: Describe dermatitis, diagnostic criteria, and treatment modalities
Dermatitis is a condition where the skin becomes inflamed. The most common types include atopic dermatitis, contact dermatitis, and seborrheic dermatitis. Patients usually complain of itching, redness, dry skin, or rashes. In some cases, there may be swelling, cracking, or small fluid-filled blisters. Diagnosis is mainly based on what the skin looks like and the patients history. For example, if someone used a new product like soap or lotion and then developed a rash, this may suggest contact dermatitis. Providers also look at patterns, such as long-term itching or a history of allergies or asthma, which is common with eczema. In some cases, patch testing is used to find the exact cause of the reaction (Eichenfield et al., 2022). Treatment focuses on controlling symptoms and avoiding triggers. Patients are encouraged to use moisturizers daily to protect the skin. Topical corticosteroids are the main treatment to reduce inflammation and itching. Antihistamines may be used to help with itching. In more severe cases, stronger medications like calcineurin inhibitors or short-term oral steroids may be needed (Eichenfield et al., 2022).
Question 2: Describe the drug therapy for Conjunctivitis and Otitis Media
Conjunctivitis, also called pink eye, can be caused by bacteria, viruses, or allergies. Bacterial conjunctivitis is treated with antibiotic eye drops such as erythromycin or trimethoprim-polymyxin B. Viral conjunctivitis usually does not need antibiotics and goes away on its own, so treatment is supportive, like using artificial tears or cold compresses. Allergic conjunctivitis is treated with antihistamines or special eye drops that reduce the allergic reaction (Azari & Barney, 2013). Otitis media is an infection of the middle ear. The first-choice treatment is amoxicillin. If the infection is more severe or the patient recently took antibiotics, amoxicillin-clavulanate may be used instead. If the patient is allergic to penicillin, other options like azithromycin can be given. Pain control is also important, so medications like acetaminophen or ibuprofen are recommended (Azari & Barney, 2013).
Question 3: Discuss Herpes Virus infections, patient presentation, and treatment
Herpes simplex virus infections include HSV-1 and HSV-2. HSV-1 usually causes cold sores around the mouth, while HSV-2 usually affects the genital area. Patients often present with painful blisters that sit on a red base. These blisters can break open and form sores. During the first outbreak, patients may also have fever, fatigue, and swollen lymph nodes. The virus stays in the body and can come back later, especially during stress or illness. Treatment includes antiviral medications such as acyclovir, valacyclovir, or famciclovir. These medications help reduce how long the outbreak lasts and make symptoms less severe. Some patients may need daily medication to prevent frequent outbreaks (Eichenfield et al., 2022).
Question 4: Describe the most common primary bacterial skin infections and the treatment of choice
The most common bacterial skin infections include impetigo, cellulitis, and folliculitis. Impetigo is common in children and shows up as honey-colored crusts on the skin. It is usually caused by bacteria like Staphylococcus aureus. Treatment includes topical antibiotics like mupirocin, or oral antibiotics if it spreads. Cellulitis is a deeper infection that causes redness, warmth, swelling, and pain. It is usually treated with oral antibiotics like cephalexin. Severe cases may need IV antibiotics. Folliculitis is an infection of the hair follicles and looks like small red bumps. Mild cases can be treated with topical antibiotics, while more serious cases may need oral medications (Azari & Barney, 2013).
References
Azari, A. A., & Barney, N. P. (2013). Conjunctivitis: A systematic review of diagnosis and treatment. JAMA, 310(16), 17211729.
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., et al. (2022). Guidelines of care for the management of atopic dermatitis. Journal of the American Academy of Dermatology, 86(3), 573594.
Leave a Reply
You must be logged in to post a comment.